Treatment of lung cancer
256 results
101 - 200Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
Psychosocial interventions for reducing fatigue during cancer treatment in adults
Palliative endobronchial brachytherapy for non‐small cell lung cancer
Concurrent chemoradiotherapy in non-small cell lung cancer: Cochrane systematic review
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults
Breast cancer
Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
Daily multivitamins have minimal, if any, effect on preventing cancer in men and do not affect mortality
Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases: Cochrane systematic review
Intermittent versus continuous androgen suppression for prostatic cancer
Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
Antibody induction therapy for lung transplant recipients
Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
Biomedical risk assessment as an aid for smoking cessation
Prolonged cough in adults
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): Cochrane systematic review
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
PSA screening has marginal effect on mortality in European study (ERSPC)
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
Management of adverse effects of radiotherapy
Vitamins E and C and selenium do not reduce risk of prostate or total cancer in men
Short term benefits for laparoscopic colorectal resection
Anticoagulation for perioperative thromboprophylaxis in people with cancer
Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy: Cochrane systematic review
Organ transplant recipient in primary health care
Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
USPSTF review of the benefits and harms of menopausal hormone therapy
Guidelines for end of life care (ACP)
Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
Cannabis‐based medicines and medical cannabis for adults with cancer pain
Lymphangitis
Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
Interventions for the management of malignant pleural effusions: a network meta‐analysis
Carotenoids and omega-3 fatty acids do not reduce risk of advanced AMD
Second‐line chemotherapy for non‐small cell lung cancer
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
Haemoptysis
Radiotherapy for early breast cancer: Cochrane systematic review
Platinum‐containing regimens for triple‐negative metastatic breast cancer
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
Anaesthetic techniques for risk of malignant tumour recurrence
Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults: Cochrane systematic review
Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
Antidepressants for depression in medical illness: Cochrane systematic review
Chemotherapy for advanced non‐small cell lung cancer in the elderly population
Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
Adverse effects of antineoplastic agents
Percutaneous ethanol injection for liver metastases
Impact of PSA screening on quality of life
Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under: Cochrane systematic review
Telephone interventions for symptom management in adults with cancer
Immunotherapy for advanced renal cell cancer: Cochrane systematic review
Cyclophosphamide for connective tissue disease–associated interstitial lung disease
Fewer overall hospital days with use of indwelling pleural catheters vs pleurodesis for malignant effusions
Epidermal growth factor receptor blockers for the treatment of ovarian cancer
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
Platinum‐containing regimens for metastatic breast cancer
Palliative treatment
Mindfulness‐based stress reduction for women diagnosed with breast cancer
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
Population screening for cancer
Alcoholic liver disease (ALD)
PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma
Topical tretinoin may increase all-cause mortality
Pneumonia
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
Golimumab for rheumatoid arthritis
Interventions for fatigue and weight loss in adults with advanced progressive illness
Genetic test results that identify increased risk do not change behavior
Antifibrinolytic therapy to reduce haemoptysis from any cause
Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
PSA for screening of prostate cancer
Lymphomas
Targeted therapy for advanced renal cell carcinoma
Antitubercular medication in ambulatory care
Unintentional weight loss in adults